Speaker illustration

Doctor Diego Lopez Otero

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)

Prevalence and prognostic impact of cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. AMY-TAVI study.

Event: ESC Congress 2022

Topic: Aortic Valve Intervention

Session: Transcatheter aortic valve implantation: trends, outcomes, and procedural considerations

Thumbnail

Prognostic impact of left ventricular ejection fraction recovery in patients undergoing pecutaneous aortic valve replacement

Event: ESC Congress 2022

Topic: Aortic Valve Intervention

Session: Aortic valve intervention 3

Thumbnail

Prognostic value of change in nutritional status after transcatheter aortic valve replacement

Event: ESC Congress 2020

Topic: Aortic Valve Intervention

Session: Interventional Cardiology ePosters

Thumbnail

Impact of coronary revascularization in patients undergoing transcatheter aortic valve implantation

Event: ESC Congress 2018

Topic: Intervention

Session: Deep dive in transcatheter aortic valve implantation

Thumbnail

Prevention of contrast-induced nephropathy with renalguard system in patients at high and very-high risk, undergoing transcatheter aortic valve implantation

Event: ESC Congress 2016

Topic: Non coronary cardiac interventions

Session: Non-coronary cardiac interventions and more

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb